AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35293006 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroups with renal and cardiac involvement
Number of subjects: 0
Study 33285469 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg intravenously every 2 weeks for up to 12 months)
Number of subjects: 713
Study 33285469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study 33127967 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesia Service Platform (ASP)
Number of subjects: 222
Study 33127967 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 222
Study 36309127 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine health status assessment via the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12)
Number of subjects: 1248
Study 36309127 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1248
Study 36309127 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine KCCQ-12 assessment
Number of subjects: 1248
Study 34449185 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated therapy (1 month of dual antiplatelet therapy)
Number of subjects: 4434
Study 34449185 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (continuation of dual antiplatelet therapy for at least 2 additional months)
Number of subjects: 4434
Study 32360692 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cannabis (12.5% THC)
Number of subjects: 91
Study 32360692 — intervention group
Group type: EXPERIMENTAL
Intervention: High THC cannabis
Number of subjects: 91
Study 32360692 — intervention group
Group type: EXPERIMENTAL
Intervention: Low THC cannabis
Number of subjects: 91
Study 32360692 — intervention group
Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 91
Study 34117180 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 104
Study 34117180 — intervention group
Group type: COMPARATOR
Intervention: DAPT
Number of subjects: 104
Study 34384737 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary health promotion program for 24 months (11 group sessions: 8 main and 3 support sessions)
Number of subjects: 92
Study 34384737 — intervention group
Group type: COMPARATOR
Intervention: Usual care at primary care level
Number of subjects: 92
Study 34591170 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric (ISO)
Number of subjects: 33
Study 34591170 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CONC)
Number of subjects: 33
Study 34591170 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric (ECC)
Number of subjects: 33
Study 34591170 — intervention group
Group type: COMPARATOR
Intervention: All groups (ISO, CONC, ECC)
Number of subjects: 33
Study 32189042 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking with pelvis perturbation force
Number of subjects: 14
Study 32189042 — intervention group
Group type: COMPARATOR
Intervention: Treadmill only
Number of subjects: 14
Study 34847035 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tVNS
Number of subjects: 28
Study 34847035 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 28
Study 35713517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib and trastuzumab with weekly paclitaxel-cisplatin neoadjuvant chemotherapy for four cycles
Number of subjects: 53
Study 33047784 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A)
Number of subjects: 245
Study 33047784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 34927293 — intervention group
Group type: EXPERIMENTAL
Intervention: M100 (100 g ML powder per sow per day)
Number of subjects: 50
Study 34927293 — intervention group
Group type: EXPERIMENTAL
Intervention: M200 (200 g ML powder per sow per day)
Number of subjects: 50
Study 34927293 — intervention group
Group type: EXPERIMENTAL
Intervention: M300 (300 g ML powder per sow per day)
Number of subjects: 50
Study 34927293 — intervention group
Group type: EXPERIMENTAL
Intervention: M400 (400 g ML powder per sow per day)
Number of subjects: 50
Study 34927293 — intervention group
Group type: COMPARATOR
Intervention: C (control group, 0 g ML powder per sow per day)
Number of subjects: 50
Study 34385704 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 94
Study 34385704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 34117835 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua‐PLYO exercises
Number of subjects: 16
Study 34117835 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient care (SoC)
Number of subjects: 16
Study 34424115 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial Asthma Action Plan (PAAP)
Number of subjects: 45
Study 34424115 — intervention group
Group type: COMPARATOR
Intervention: Written Asthma Action Plan (WAAP)
Number of subjects: 45
Study 34668795 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal nonopioid analgesic protocol (acetaminophen, ketorolac, diazepam, gabapentin, and meloxicam)
Number of subjects: 62
Study 34668795 — intervention group
Group type: COMPARATOR
Intervention: Standard opioid regimen (hydrocodone‐acetaminophen)
Number of subjects: 62
Study 34668795 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal nonopioid analgesic protocol
Number of subjects: 62
Study 34668795 — intervention group
Group type: COMPARATOR
Intervention: Standard opioid regimen
Number of subjects: 62
Study 34668795 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 32613525 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile After-Care Support (MACS)
Number of subjects: 10
Study 32825556 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg EGCG
Number of subjects: 14
Study 34727317 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 953
Study 35331859 — intervention group
Group type: EXPERIMENTAL
Intervention: IA-HA (2,700 kDa HA, 5 times at 1-week intervals)
Number of subjects: 200
Study 35331859 — intervention group
Group type: COMPARATOR
Intervention: NSAID (loxoprofen sodium, 180 mg/day for 5 weeks)
Number of subjects: 200
Study 33038521 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical end-to-end anastomosis
Number of subjects: 33
Study 33038521 — intervention group
Group type: COMPARATOR
Intervention: Side-to-end anastomosis
Number of subjects: 33
Study 33038521 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-end anastomosis (subanalysis of low-mid rectum tumors)
Number of subjects: 33
Study 33038521 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment
Number of subjects: 33
Study 35641198 — intervention group
Group type: EXPERIMENTAL
Intervention: Married
Number of subjects: 1082
Study 35641198 — intervention group
Group type: COMPARATOR
Intervention: Divorced/Separated/Widowed
Number of subjects: 1082
Study 35641198 — intervention group
Group type: COMPARATOR
Intervention: Living with other family
Number of subjects: 1082
Study 35641198 — intervention group
Group type: COMPARATOR
Intervention: Living alone
Number of subjects: 1082
Study 33407791 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of exercise and education (Good Life with osteoarthritis in Denmark; GLAD)
Number of subjects: 200
Study 33407791 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injections of 5 ml isotonic saline every second week for a total of 4 injections
Number of subjects: 200
Study 33407791 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of exercise and education (GLAD)
Number of subjects: 200
Study 32871881 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 100
Study 32871881 — intervention group
Group type: COMPARATOR
Intervention: Epidural Analgesia (EA)
Number of subjects: 100
Study 34467386 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music intervention with standard care
Number of subjects: 33
Study 34467386 — intervention group
Group type: COMPARATOR
Intervention: Recorded music intervention with standard care
Number of subjects: 33
Study 34837890 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible airway scope (FAS)
Number of subjects: 4
Study 34837890 — intervention group
Group type: COMPARATOR
Intervention: Retrograde intubation technique (RIT)
Number of subjects: 4
Study 34837890 — intervention group
Group type: COMPARATOR
Intervention: Comparison of FAS and RIT
Number of subjects: 4
Study 34473194 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensartinib, 225 mg once daily
Number of subjects: 290
Study 34473194 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib, 250 mg twice daily
Number of subjects: 290
Study 34473194 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensartinib
Number of subjects: 290
Study 34473194 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 290
Study 33180670 — intervention group
Group type: EXPERIMENTAL
Intervention: AS04-adjuvanted HPV-16/18 vaccine
Number of subjects: 871
Study 32741240 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month social ballroom dancing intervention
Number of subjects: 32
Study 32741240 — intervention group
Group type: COMPARATOR
Intervention: 6-month active control intervention (treadmill walking)
Number of subjects: 32
Study 34764183 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week twice-weekly regimen of rifapentine plus isoniazid
Number of subjects: 2449
Study 34764183 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 2449
Study 33516273 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs (rs11682128, rs601945, rs3935067, rs679515)
Number of subjects: 0
Study 33516273 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential expression analysis of BIN1 gene
Number of subjects: 0
Study 32827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless laparoscopic (GAL) procedures
Number of subjects: 100
Study 32827645 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic (COL) operations
Number of subjects: 100
Study 35580967 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 216
Study 35580967 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 216
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed hard copy binder
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive website (https://www.task3web.com/)
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: eBook
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: USB drive
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone calls with nurse
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: FaceTime on iOS device
Number of subjects: 22
Study 33075163 — intervention group
Group type: EXPERIMENTAL
Intervention: Online videoconferencing
Number of subjects: 22
Study 32070472 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Asthma Education Program (eAEP)
Number of subjects: 82
Study 32070472 — intervention group
Group type: COMPARATOR
Intervention: Conventional face-to-face Asthma Education Program (pAEP)
Number of subjects: 82
Study 32070472 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Asthma Education Program (eAEP) after pAEP
Number of subjects: 82
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue (CRF) trajectory - Always present
Number of subjects: 202
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue (CRF) trajectory - Subsided
Number of subjects: 202
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue (CRF) trajectory - Developed
Number of subjects: 202
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue (CRF) trajectory - Never present
Number of subjects: 202
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impact of CRF on HRQOL
Number of subjects: 202
Study 35835613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue management
Number of subjects: 202
Study 34672928 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day acceptance and commitment therapy (ACT) workshop
Number of subjects: 72
Study 34672928 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 72
Study 36017745 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 1134
Study 36916653 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroids (TCS)
Number of subjects: 152
Study 36916653 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus (TAC)
Number of subjects: 152
Study 33542412 — intervention group
Group type: COMPARATOR
Intervention: Hylan G-F 20 (HG)
Number of subjects: 100
Study 33542412 — intervention group
Group type: COMPARATOR
Intervention: Platelet concentrate (PCG)
Number of subjects: 100
Study 33542412 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone hexacetonide (THG)
Number of subjects: 100
Study 33542412 — intervention group
Group type: COMPARATOR
Intervention: Stanozolol (SG)
Number of subjects: 100
Study 33542412 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 100
Study 32482355 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 μg.kg−1 remifentanil combined with propofol
Number of subjects: 105
Study 32482355 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 μg.kg−1 remifentanil combined with propofol
Number of subjects: 105
Study 32482355 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone (Control Group)
Number of subjects: 105
Study 34968635 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco-Free Duo (T-Duo) multi-component intervention
Number of subjects: 1776
Study 34968635 — intervention group
Group type: COMPARATOR
Intervention: Standardized educational component (control)
Number of subjects: 1776
Study 34886324 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) stove and fuel intervention (n = 1590)
Number of subjects: 3195
Study 34886324 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 1605)
Number of subjects: 3195
Study 32159606 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal to Plantar screw orientation (DP Group)
Number of subjects: 16
Study 32159606 — intervention group
Group type: COMPARATOR
Intervention: Plantar to Dorsal screw orientation (PD Group)
Number of subjects: 16
Study 35224781 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 commercially available sunscreens
Number of subjects: 20
Study 32861273 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib plus carboplatin and paclitaxel
Number of subjects: 513
Study 32861273 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus carboplatin and paclitaxel
Number of subjects: 513
Study 32861273 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib
Number of subjects: 513
Study 32861273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 36341961 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component interventions tailored to FCG needs
Number of subjects: 0
Study 36341961 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized terminology and pathway for tailoring intervention components
Number of subjects: 0
Study 34770104 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min exercise (high-intensity intermittent running)
Number of subjects: 38
Study 34770104 — intervention group
Group type: COMPARATOR
Intervention: 60 min exercise (high-intensity intermittent running)
Number of subjects: 38
Study 34770104 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 38
Study 32155382 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention using WhatsApp messaging (55 audio, image or text messages) plus usual care (multi‐professional educational appointments)
Number of subjects: 403
Study 32155382 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 403
Study 34156650 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming intervention
Number of subjects: 35
Study 34005897 — intervention group
Group type: EXPERIMENTAL
Intervention: α model (targeted percolation with incomplete knowledge)
Number of subjects: 0
Study 34005897 — intervention group
Group type: EXPERIMENTAL
Intervention: β model (mirror image process targeting the lowest degree node)
Number of subjects: 0
Study 34298389 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes open and focused during MRI acquisition
Number of subjects: 77
Study 34298389 — intervention group
Group type: COMPARATOR
Intervention: Eyes closed during MRI acquisition
Number of subjects: 77
Study 32067341 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Calorie Diet (VLCD) program for 8 weeks incorporating Optifast shakes
Number of subjects: 46
Study 32067341 — intervention group
Group type: COMPARATOR
Intervention: Standard care (generic healthy eating information)
Number of subjects: 46
Study 33217220 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillomandibular fixation (MMF) with orthodontic bracket‐elastic, immobilization for 2 weeks and guiding elastics for 1 week
Number of subjects: 17
Study 32054559 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0
Study 32054559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36001000 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 121
Study 36001000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 34212195 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) 3 or 6 million units/m2
Number of subjects: 35
Study 34212195 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 35
Study 32610864 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral iron supplementation (60mg of elemental iron, ferrous sulfate)
Number of subjects: 40
Study 32610864 — intervention group
Group type: COMPARATOR
Intervention: Alternate day oral iron supplementation (60mg of elemental iron, ferrous sulfate)
Number of subjects: 40
Study 32610864 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral iron supplementation
Number of subjects: 40
Study 32610864 — intervention group
Group type: COMPARATOR
Intervention: Alternate day oral iron supplementation
Number of subjects: 40
Study 36120967 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjoint Behavioral Consultation (CBC)
Number of subjects: 30
Study 36120967 — intervention group
Group type: COMPARATOR
Intervention: School-as-usual
Number of subjects: 30
Study 34105575 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 whole Gala apples (∼200 g)
Number of subjects: 26
Study 35142833 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Assisted Cognitive Behavior Therapy (CCBT)
Number of subjects: 175
Study 35142833 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 175
Study 33361317 — intervention group
Group type: EXPERIMENTAL
Intervention: Navy bean intervention (35 g bean powder/day)
Number of subjects: 20
Study 33361317 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g/day)
Number of subjects: 20
Study 34383381 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC + cytosine arabinoside (Ara‐C) therapy (30 mg/30 mL + 200 mg/10 mL) for 6 weeks
Number of subjects: 165
Study 34383381 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) therapy (30 mg/40 mL) for 6 weeks
Number of subjects: 165
Study 34383381 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC + Ara‐C therapy
Number of subjects: 165
Study 34383381 — intervention group
Group type: COMPARATOR
Intervention: MMC therapy
Number of subjects: 165
Study 34383381 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC and Ara‐C therapy
Number of subjects: 165
Study 33610093 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation + Contingency Management (PN + CM)
Number of subjects: 801
Study 33610093 — intervention group
Group type: COMPARATOR
Intervention: Patient Navigation alone (PN)
Number of subjects: 801
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 10-second ECG
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily 30-second ECGs during 14 days
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 24-hour continuous monitoring
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 48-hour continuous monitoring
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 72-hour continuous monitoring
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 7-day continuous monitoring
Number of subjects: 590
Study 32114796 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 30-day continuous monitoring
Number of subjects: 590
Study 36004636 — intervention group
Group type: EXPERIMENTAL
Intervention: CleanViewAL®
Number of subjects: 173
Study 36004636 — intervention group
Group type: COMPARATOR
Intervention: Plenvu®
Number of subjects: 173
Study 33560531 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐endo Shaper
Number of subjects: 60
Study 33560531 — intervention group
Group type: COMPARATOR
Intervention: iRaCe rotary files
Number of subjects: 60
Study 32807179 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIT)
Number of subjects: 81
Study 32807179 — intervention group
Group type: COMPARATOR
Intervention: Moderate intensity continuous training (MICT)
Number of subjects: 81
Study 35412010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (weight loss intervention)
Number of subjects: 0
Study 35412010 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (control)
Number of subjects: 0
Study 34677629 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tourniquet (Group A)
Number of subjects: 90
Study 34677629 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet (Group B)
Number of subjects: 90
Study 34116911 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 46
Study 34116911 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral Approach (PLA)
Number of subjects: 46
Study 34116911 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 46